JANNEY DANIEL (CIK 1198325) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell KRYS (9,430 shares), Sell KRYS (2,373 shares), Buy KRYS (37,895 shares), Sell KRYS (569 shares), Sell KRYS (1,733 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 9,430 | $2.6M |
| 2026-03-03 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 2,373 | $655,351 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Buy | 37,895 | $93,222 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 569 | $149,596 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 1,733 | $457,720 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 3,557 | $942,890 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 8,986 | $2.4M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 11,673 | $3.1M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 6,671 | $1.8M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 3,963 | $1.1M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 370 | $99,837 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 373 | $101,117 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 62 | $16,309 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 900 | $238,140 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 1,604 | $425,926 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 4,339 | $1.2M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 1,891 | $505,597 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 1,674 | $449,754 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 930 | $250,635 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 2,425 | $666,632 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 700 | $192,500 |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 5,103 | $1.4M |
| 2026-02-26 | Krystal Biotech, Inc. (KRYS) | Director | Sell | 2,638 | $728,932 |
Source: SEC Form 4 filings · as of 2026-03-03